BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35618935)

  • 21. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
    Rajendran P; Delage B; Dashwood WM; Yu TW; Wuth B; Williams DE; Ho E; Dashwood RH
    Mol Cancer; 2011 May; 10():68. PubMed ID: 21624135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.
    Sun Z; Feng D; Fang B; Mullican SE; You SH; Lim HW; Everett LJ; Nabel CS; Li Y; Selvakumaran V; Won KJ; Lazar MA
    Mol Cell; 2013 Dec; 52(6):769-82. PubMed ID: 24268577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Balanced control of thermogenesis by nuclear receptor corepressors in brown adipose tissue.
    Richter HJ; Hauck AK; Batmanov K; Inoue SI; So BN; Kim M; Emmett MJ; Cohen RN; Lazar MA
    Proc Natl Acad Sci U S A; 2022 Aug; 119(33):e2205276119. PubMed ID: 35939699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circular RNA circ-NCOR2 accelerates papillary thyroid cancer progression by sponging miR-516a-5p to upregulate metastasis-associated protein 2 expression.
    Luan S; Fu P; Wang X; Gao Y; Shi K; Guo Y
    J Int Med Res; 2020 Sep; 48(9):300060520934659. PubMed ID: 32940102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulated clearance of histone deacetylase 3 protects independent formation of nuclear receptor corepressor complexes.
    Guo C; Gow CH; Li Y; Gardner A; Khan S; Zhang J
    J Biol Chem; 2012 Apr; 287(15):12111-20. PubMed ID: 22337871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K; Pašková L; Matiješčuková N; Kolář Z
    Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response.
    Long J; Fang WY; Chang L; Gao WH; Shen Y; Jia MY; Zhang YX; Wang Y; Dou HB; Zhang WJ; Zhu J; Liang AB; Li JM; Hu J
    Leukemia; 2017 Dec; 31(12):2761-2770. PubMed ID: 28462918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
    Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
    J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of function of NCOR1 and NCOR2 impairs memory through a novel GABAergic hypothalamus-CA3 projection.
    Zhou W; He Y; Rehman AU; Kong Y; Hong S; Ding G; Yalamanchili HK; Wan YW; Paul B; Wang C; Gong Y; Zhou W; Liu H; Dean J; Scalais E; O'Driscoll M; Morton JEV; ; Hou X; Wu Q; Tong Q; Liu Z; Liu P; Xu Y; Sun Z
    Nat Neurosci; 2019 Feb; 22(2):205-217. PubMed ID: 30664766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous isolation of hormone receptor-positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms.
    Hogstrom JM; Cruz KA; Selfors LM; Ward MN; Mehta TS; Kanarek N; Philips J; Dialani V; Wulf G; Collins LC; Patel JM; Muranen T
    J Biol Chem; 2023 Aug; 299(8):105021. PubMed ID: 37423299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDAC3 ensures stepwise epidermal stratification via NCoR/SMRT-reliant mechanisms independent of its histone deacetylase activity.
    Szigety KM; Liu F; Yuan CY; Moran DJ; Horrell J; Gochnauer HR; Cohen RN; Katz JP; Kaestner KH; Seykora JT; Tobias JW; Lazar MA; Xu M; Millar SE
    Genes Dev; 2020 Jul; 34(13-14):973-988. PubMed ID: 32467224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p.
    Chen Z; Pei L; Zhang D; Xu F; Zhou E; Chen X
    Int J Biochem Cell Biol; 2021 Jun; 135():105967. PubMed ID: 33727043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2.
    Leung MH; Tsoi H; Gong C; Man EP; Zona S; Yao S; Lam EW; Khoo US
    Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32110852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
    Sharma D; Saxena NK; Davidson NE; Vertino PM
    Cancer Res; 2006 Jun; 66(12):6370-8. PubMed ID: 16778215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.
    Campos B; Bermejo JL; Han L; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Herold-Mende C
    Cancer Sci; 2011 Feb; 102(2):387-92. PubMed ID: 21143702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity.
    Banik D; Khan AN; Walseng E; Segal BH; Abrams SI
    PLoS One; 2012; 7(9):e45422. PubMed ID: 23028998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo.
    You SH; Lim HW; Sun Z; Broache M; Won KJ; Lazar MA
    Nat Struct Mol Biol; 2013 Feb; 20(2):182-7. PubMed ID: 23292142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In cortical neurons HDAC3 activity suppresses RD4-dependent SMRT export.
    Soriano FX; Hardingham GE
    PLoS One; 2011; 6(6):e21056. PubMed ID: 21695276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of chemotherapy and P2Et extract combination in ex-vivo derived tumor mammospheres from breast cancer patients.
    Urueña C; Sandoval TA; Lasso P; Tawil M; Barreto A; Torregrosa L; Fiorentino S
    Sci Rep; 2020 Nov; 10(1):19639. PubMed ID: 33184339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.